[Possibilities and limitations of immunosuppressive treatment].
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001666:Binding Sites, Antibody; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D004322:Drainage; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects; D008212:Lymphocyte Depletion; D008297:Male; D051379:Mice; D011247:Pregnancy; D011830:Radiation Effects; D016038:Skin Transplantation; D013897:Thoracic Duct; D013950:Thymus Gland / Q000528:radiation effects; D014181:Transplantation Immunology / Q000187:drug effects*; D014184:Transplantation, Homologous
D000903:Antibiotics, Antineoplastic; D000961:Antilymphocyte Serum; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D006046:Gold
Möglichkeiten und Grenzen der immunsuppressiven Behandlung